These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28656100)

  • 1. Efficacy of Human Papillomavirus L1 Protein Vaccines (Cervarix and Gardasil) in Reducing the Risk of Cervical Intraepithelial Neoplasia: A Meta-analysis.
    Haghshenas MR; Mousavi T; Kheradmand M; Afshari M; Moosazadeh M
    Int J Prev Med; 2017; 8():44. PubMed ID: 28656100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current prophylactic HPV vaccines and gynecologic premalignancies.
    Harper DM
    Curr Opin Obstet Gynecol; 2009 Dec; 21(6):457-64. PubMed ID: 19923989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus vaccines.
    Schmiedeskamp MR; Kockler DR
    Ann Pharmacother; 2006; 40(7-8):1344-52. PubMed ID: 16849621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis.
    Malagón T; Drolet M; Boily MC; Franco EL; Jit M; Brisson J; Brisson M
    Lancet Infect Dis; 2012 Oct; 12(10):781-9. PubMed ID: 22920953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis of L1-VLP-based human papillomavirus vaccine efficacy against anogenital pre-cancer in women with evidence of prior HPV exposure.
    Miltz A; Price H; Shahmanesh M; Copas A; Gilson R
    PLoS One; 2014; 9(3):e90348. PubMed ID: 24595046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.
    Schwarz TF
    Adv Ther; 2009 Nov; 26(11):983-98. PubMed ID: 20024678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years.
    Einstein MH; Baron M; Levin MJ; Chatterjee A; Edwards RP; Zepp F; Carletti I; Dessy FJ; Trofa AF; Schuind A; Dubin G;
    Hum Vaccin; 2009 Oct; 5(10):705-19. PubMed ID: 19684472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Therapeutic Effect of Quadrivalent Human Papillomavirus (HPV) Vaccination on Cervical Intraepithelial Neoplasia Lesions.
    Shiravani Z; Nazari Z; Yazdani F; Najib FS; Jahromi MA; Momtahan M; Pourseyed S; Moradialamdarloo S; Tafti MH
    Indian J Surg Oncol; 2023 Jun; 14(2):504-509. PubMed ID: 37324297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results.
    Schiller JT; Castellsagué X; Villa LL; Hildesheim A
    Vaccine; 2008 Aug; 26 Suppl 10(Suppl 10):K53-61. PubMed ID: 18847557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus vaccination in adolescence.
    Russell M; Raheja V; Jaiyesimi R
    Perspect Public Health; 2013 Nov; 133(6):320-4. PubMed ID: 24006173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cost-Effectiveness Analysis of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) for Females in Japan.
    Yamabe K; Singhal PK; Abe M; Dasbach EJ; Elbasha EH
    Value Health Reg Issues; 2013 May; 2(1):92-97. PubMed ID: 29702859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial.
    Toft L; Storgaard M; Müller M; Sehr P; Bonde J; Tolstrup M; Østergaard L; Søgaard OS
    J Infect Dis; 2014 Apr; 209(8):1165-73. PubMed ID: 24273179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines for the prevention of human papillomavirus infections.
    Speck LM; Tyring SK
    Skin Therapy Lett; 2006; 11(6):1-3. PubMed ID: 16912836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes.
    Barzon L; Squarzon L; Masiero S; Pacenti M; Marcati G; Mantelli B; Gabrielli L; Pascucci MG; Lazzarotto T; Caputo A; Palù G
    Vaccine; 2014 Sep; 32(41):5357-62. PubMed ID: 25045814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination.
    Roy V; Jung W; Linde C; Coates E; Ledgerwood J; Costner P; Yamshchikov G; Streeck H; Juelg B; Lauffenburger DA; Alter G
    NPJ Vaccines; 2023 Mar; 8(1):39. PubMed ID: 36922512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus.
    Kash N; Lee MA; Kollipara R; Downing C; Guidry J; Tyring SK
    J Clin Med; 2015 Apr; 4(4):614-33. PubMed ID: 26239350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer: screening and prevention.
    Behtash N; Mehrdad N
    Asian Pac J Cancer Prev; 2006; 7(4):683-6. PubMed ID: 17250453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine.
    Bryan JT; Buckland B; Hammond J; Jansen KU
    Curr Opin Chem Biol; 2016 Jun; 32():34-47. PubMed ID: 26994695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus.
    Herrin DM; Coates EE; Costner PJ; Kemp TJ; Nason MC; Saharia KK; Pan Y; Sarwar UN; Holman L; Yamshchikov G; Koup RA; Pang YY; Seder RA; Schiller JT; Graham BS; Pinto LA; Ledgerwood JE
    Hum Vaccin Immunother; 2014; 10(12):3446-54. PubMed ID: 25483691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection.
    Zurek Munk-Madsen M; Toft L; Kube T; Richter R; Ostergaard L; Søgaard OS; Tolstrup M; Kaufmann AM
    Hum Vaccin Immunother; 2018 Apr; 14(4):909-916. PubMed ID: 29172992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.